Ticagrelor for acute coronary syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 19 registered trials.

Why this status

  1. 5 Dec 2012: Trial registered, NCT01742117
  2. 6 Jun 2013: Trial registered, NCT01870921
  3. 26 Jun 2013: Trial started, NCT01870921
  4. 10 Jul 2015: Trial registered, NCT02494895
  5. 1 Aug 2015: Trial started, NCT02494895
  6. 22 Dec 2017: Trial registered, NCT03381755
  7. 1 Jan 2018: Trial started, NCT03381755
  8. 31 Oct 2020: Trial completed, NCT01742117
  9. 22 Jan 2021: Trial registered, NCT04718025
  10. 7 Feb 2022: Trial started, NCT04718025
  11. 2 Apr 2026: Trial registered, NCT07507500
  12. 2 Sep 2026: Trial started, NCT07507500

The trials

NCT01360437: Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention

State
Completed
Phase
Phase 3
People
44 taking part
Started
May 2011
Primary completion
Dec 2011
Arms
Ticagrelor
Results
None posted
Papers
doi:10.1016/j.jacc.2012.03.050
  1. 25 May 2011: Trial registered

NCT01603082: Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome Patients

State
Completed
Phase
Phase 4
People
343 taking part
Started
Jul 2012
Primary completion
Jun 2014
Arms
Ticagrelor
Results
Posted on the registry
Papers
doi:10.1016/j.jacc.2015.11.044, doi:10.1161/jaha.117.005650
  1. 22 May 2012: Trial registered
  2. 11 Dec 2015: Trial results posted

NCT01642940: Τicagrelor Versus Prasugrel in Diabetic Patients: a Pharmacodynamic Study

State
Completed
Phase
Phase 4
People
30 taking part
Started
Jun 2012
Primary completion
Sep 2012
Arms
Ticagrelor
Results
None posted
Papers
doi:10.2337/dc12-2510
  1. 17 Jul 2012: Trial registered

NCT01742117: Tailored Antiplatelet Therapy Following PCI

State
Completed
Phase
Phase 4
People
5,276 taking part
Started
May 2013
Primary completion
31 Oct 2020
Arms
Genotype-Guided Therapy
Results
Posted on the registry
Papers
doi:10.1001/jama.2020.12443, doi:10.1007/s10557-022-07392-2, doi:10.1016/j.jcin.2023.01.356, doi:10.1038/s41397-022-00278-4, doi:10.1111/cts.70655, doi:10.1161/jaha.121.024156, doi:10.1161/jaha.121.024709, doi:10.2196/34080
  1. 5 Dec 2012: Trial registered
  2. 31 Oct 2020: Trial completed
  3. 9 Nov 2021: Trial results posted

NCT01826175: Comparison of Ticagrelor Versus Clopidogrel on Residual Thrombus Burden During PCI: an OCT Study

State
Withdrawn before it started
Phase
Phase 4
People
0 taking part
Started
May 2013
Primary completion
May 2014
Arms
Ticagrelor
Results
None posted
  1. 8 Apr 2013: Trial registered
  2. 20 Dec 2016: Trial withdrawn

NCT01870921: Brilinta DaYu Study

State
Completed
Phase
Phase 4
People
2,004 taking part
Started
26 Jun 2013
Primary completion
30 Sep 2015
Arms
Ticargrelor
Results
Posted on the registry
  1. 6 Jun 2013: Trial registered
  2. 26 Jun 2013: Trial started
  3. 30 Sep 2015: Trial completed
  4. 9 Nov 2016: Trial results posted

NCT01994941: Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome

State
Completed
Phase
Phase 4
People
133 taking part
Started
Aug 2013
Primary completion
Aug 2015
Arms
Genotype guided group
Results
None posted
Papers
doi:10.1177/0300060516677190
  1. 26 Nov 2013: Trial registered

NCT02016170: Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor

State
Completed
Phase
No phase
People
82 taking part
Started
Mar 2014
Primary completion
Oct 2015
Arms
Ticagrelor 180mg, Ticagrelor 90mg
Results
Posted on the registry
Papers
doi:10.1016/j.jcin.2016.02.039
  1. 19 Dec 2013: Trial registered
  2. 18 Oct 2016: Trial results posted

NCT02037412: Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome

State
Stopped early
Phase
Phase 4
People
148 taking part
Started
Jan 2014
Primary completion
30 Sep 2016
Arms
Ticagrelor Arm
Results
None posted
  1. 15 Jan 2014: Trial registered
  2. 30 Sep 2016: Trial terminated

NCT02201667: Efficacy of Ticagrelor vs Clopidogrel in High-risk NSTE-ACS Patients Undergoing Early PCI

State
State not given
Phase
Phase 4
People
444 planned
Started
Aug 2014
Primary completion
Aug 2016
Arms
Ticagrelor group
Results
None posted
  1. 28 Jul 2014: Trial registered

NCT02494895: Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)

State
State not given
Phase
Phase 4
People
3,056 planned
Started
1 Aug 2015
Primary completion
May 2023
Arms
Ticagrelor monotherapy
Results
None posted
Papers
doi:10.1001/jama.2020.7580, doi:10.1016/j.jcin.2020.11.036, doi:10.1038/s41598-021-91130-5, doi:10.1161/circinterventions.121.010812, doi:10.1161/jaha.120.019630, doi:10.3389/fcvm.2023.1128834, doi:10.3389/fcvm.2023.1237826, doi:10.3389/fphar.2020.620906, doi:10.4070/kcj.2021.0321, doi:10.4070/kcj.2025.0093, doi:10.4244/eij-d-25-00832
  1. 10 Jul 2015: Trial registered
  2. 1 Aug 2015: Trial started

NCT02725099: Chewing Versus Traditional Oral Administration of Ticagrelor in STEMI Patients

State
Completed
Phase
Phase 4
People
50 taking part
Started
May 2016
Primary completion
Jan 2017
Arms
Chewing Ticagrelor
Results
None posted
Papers
doi:10.1001/jamacardio.2017.3868
  1. 31 Mar 2016: Trial registered

NCT02792712: Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI

State
State not given
Phase
Phase 4
People
200 planned
Started
Jan 2016
Primary completion
Jan 2018
Arms
STEMI_MRI_Ticagrelor
Results
None posted
  1. 7 Jun 2016: Trial registered

NCT02944123: Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)

State
Completed
Phase
Phase 3
People
120 taking part
Started
Sep 2016
Primary completion
Feb 2020
Arms
Ticagrelor 45 mg
Results
None posted
  1. 25 Oct 2016: Trial registered

NCT03381755: Low-dose Ticagrelor in Chinese ACS Patients Undergoing PCI

State
State not given
Phase
Phase 4
People
200 planned
Started
1 Jan 2018
Primary completion
14 Dec 2019
Arms
half-dose ticagrelor
Results
None posted
  1. 22 Dec 2017: Trial registered
  2. 1 Jan 2018: Trial started

NCT04718025: Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome

State
State not given
Phase
Phase 3
People
4,500 planned
Started
7 Feb 2022
Primary completion
30 Jun 2024
Arms
Low-dose ticagrelor with aspirin (LDTA), Low-dose ticagrelor with placebo (LDTP)
Results
None posted
Papers
doi:10.5603/cj.a2021.0056
  1. 22 Jan 2021: Trial registered
  2. 7 Feb 2022: Trial started

NCT07507500: Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 Months

State
Under way
Phase
Phase 4
People
8,100 planned
Started
2 Sep 2026
Primary completion
Jul 2029
Arms
Ticagrelor 12 months DAPT, Ticagrelor abbreviated DAPT
Results
None posted
  1. 2 Apr 2026: Trial registered
  2. 2 Sep 2026: Trial started

How the status changed

  1. 16 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Brilinta, Brilique, Chewing Ticagrelor, Possia, Ticagrelor 180mg, Ticagrelor 45 mg, Ticagrelor 60mg, Ticagrelor 90mg, Ticagrelor 90mg for 6-month (immediately after PCI), Ticagrelor 90mg/60mg, Ticagrelor monotherapy, half-dose ticagrelor, low-dose ticagrelor.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.